Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Friday, May 02, 2025
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Posted On Friday, May 02, 2025
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Cartesian Therapeutics Announces New Employment Inducement Grants
Posted On Friday, May 02, 2025
Metagenomi to Present at Upcoming Scientific Meetings
Posted On Friday, May 02, 2025
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
Posted On Friday, May 02, 2025
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
Posted On Friday, May 02, 2025
EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
Posted On Friday, May 02, 2025
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
Posted On Friday, May 02, 2025
Coherus to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, May 01, 2025
Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules
Posted On Thursday, May 01, 2025
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
Posted On Thursday, May 01, 2025
MacroGenics to Participate in Upcoming Investor Conference
Posted On Thursday, May 01, 2025
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
Posted On Thursday, May 01, 2025
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Thursday, May 01, 2025
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy
Posted On Thursday, May 01, 2025
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, May 01, 2025
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Posted On Thursday, May 01, 2025
Kura Oncology Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
Posted On Thursday, May 01, 2025
NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Posted On Thursday, May 01, 2025
Sutro Biopharma to Participate in Upcoming Investor Conferences
Posted On Thursday, May 01, 2025
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
Posted On Thursday, May 01, 2025

Print